Ichor Life Sciences

CRO & CDMO Services · Health Care

Overview

Overcome your most demanding challenges with our curated team of highly experienced scientists and our extensive list of CRO services. Learn more.

Investor profile

Corporate investor
Investments
1
1 of them startups
Hiring now
0
companies with open roles
Focusshare of its companies
Biotechnology 100%
Stage of its companies
Pre-seed & seed 100%
Sources: 1 rounds in the press that name it

Financials

Total raised
$300k
Latest round
Grant
Funding rounds
1
Funding rounds
Round Announced Amount
Grant 2022 $300k Details

News

News Nature Index 1 year ago
Ichor Life Sciences Inc.
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Ichor Life Sciences Inc. reflects the research output of authors from Ichor Life Sciences Inc. who published articles in the 145 journ
Read more
Report
News WRAL News 2 years ago
Markets & Stocks
Stock quotes, market indicators and the latest market news.
Read more
Report
Blog 2 years ago
Ichor Life Sciences Expands Ichor Clinical to Australia, Europe, and UK
LAFAYETTE, NY - January 24, 2024 - Ichor Life Sciences, a full-service, end-to-end contract research organization (CRO) and longevity biotechnology company, has set the stage for an exciting global advance in clinical trial services. Today, the company an
Read more
Report
Blog 3 years ago
Ichor Life Sciences Announces Launch of Ichor Clinical Trial Services
LAFAYETTE, NY - November 14, 2023 - Ichor Life Sciences, a full-service contract research organization (CRO) and longevity biotechnology company, today announced the launch of Ichor Clinical Trial Services. With the founding of Ichor Clinical, the company
Read more
Report
Blog 4 years ago
Ichor Publishes Article Unraveling Evolutionary Mechanisms of Phase Separation Proteins in Extreme Microorganisms
Lafayette, N.Y. - September 8, 2022 - Ichor Life Sciences, a premium preclinical research organization, recently published an article in collaboration with SUNY-Upstate Medical University. The article, "Coevolution of the Ess1-CTD axis in polar fungi sugg
Read more
Report
News Star Tribune 4 years ago
Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Read more
Report
Press release 4 years ago
Lento Bio Raises $680,000 in Oversubscribed Seed Round Led by Ichor Life Sciences
Potsdam, N.Y. - September 6, 2022 - Lento Bio, Inc., a preclinical pharmaceutical company developing small-molecule therapeutics to restore ocular lens flexibility and near-vision in presbyopia patients, announced today they have raised $680,000 in fundin
Read more
Report
News YahooFinance 4 years ago
Ichor Life Sciences Invests $1.5 Million in MitoChem Therapeutics for Ocular Aging Disease Research
Ichor Life Sciences, a preclinical contract research organization, today announced a $1.5 million investment in MitoChem Therapeutics.
Read more
Report
Show more news